These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15642545)

  • 1. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions.
    Nakamura S; Muthusamy TS; Bae JH; Cahyadi YH; Udayachalerm W; Tresukosol D
    Am J Cardiol; 2005 Jan; 95(2):161-6. PubMed ID: 15642545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial.
    Rubartelli P; Petronio AS; Guiducci V; Sganzerla P; Bolognese L; Galli M; Sheiban I; Chirillo F; Ramondo A; Bellotti S;
    Eur Heart J; 2010 Aug; 31(16):2014-20. PubMed ID: 20566487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry.
    García-García HM; Daemen J; Kukreja N; Tanimoto S; van Mieghem CA; van der Ent M; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):635-9. PubMed ID: 17960629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions.
    Ge L; Iakovou I; Cosgrave J; Chieffo A; Montorfano M; Michev I; Airoldi F; Carlino M; Melzi G; Sangiorgi GM; Corvaja N; Colombo A
    Eur Heart J; 2005 Jun; 26(11):1056-62. PubMed ID: 15817605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions.
    Hoye A; Tanabe K; Lemos PA; Aoki J; Saia F; Arampatzis C; Degertekin M; Hofma SH; Sianos G; McFadden E; van der Giessen WJ; Smits PC; de Feyter PJ; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2004 Jun; 43(11):1954-8. PubMed ID: 15172397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
    Yachi S; Tanabe K; Tanimoto S; Aoki J; Nakazawa G; Yamamoto H; Otsuki S; Yagishita A; Kishi S; Nakano M; Taniwaki M; Sasaki S; Nakajima H; Mise N; Sugimoto T; Hara K
    Am J Kidney Dis; 2009 Aug; 54(2):299-306. PubMed ID: 19394736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.
    Iakovou I; Ge L; Michev I; Sangiorgi GM; Montorfano M; Airoldi F; Chieffo A; Stankovic G; Vitrella G; Carlino M; Corvaja N; Briguori C; Colombo A
    J Am Coll Cardiol; 2004 Sep; 44(5):967-71. PubMed ID: 15337205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year follow-up of sirolimus-eluting stents for the treatment of proximal left anterior descending coronary artery stenosis.
    Valencia J; Berenguer A; Mainar V; Bordes P; Gómez S; Tello A; López-Aranda MA; Caturla J
    J Interv Cardiol; 2006 Apr; 19(2):126-34. PubMed ID: 16650240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
    Baumgart D; Klauss V; Baer F; Hartmann F; Drexler H; Motz W; Klues H; Hofmann S; Völker W; Pfannebecker T; Stoll HP; Nickenig G;
    J Am Coll Cardiol; 2007 Oct; 50(17):1627-34. PubMed ID: 17950142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
    Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
    J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent in chronic total occlusion: the SICTO study.
    Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W
    J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?
    Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P
    J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
    Morice MC; Serruys PW; Barragan P; Bode C; Van Es GA; Stoll HP; Snead D; Mauri L; Cutlip DE; Sousa E
    J Am Coll Cardiol; 2007 Oct; 50(14):1299-304. PubMed ID: 17903626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.
    Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG
    Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific outcomes after sirolimus-eluting stent implantation.
    Solinas E; Nikolsky E; Lansky AJ; Kirtane AJ; Morice MC; Popma JJ; Schofer J; Schampaert E; Pucelikova T; Aoki J; Fahy M; Dangas GD; Moses JW; Cutlip DE; Leon MB; Mehran R
    J Am Coll Cardiol; 2007 Nov; 50(22):2111-6. PubMed ID: 18036446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.